In this video from the American Society of Retina Specialists annual meeting, Charles C. Wykoff, MD, PhD, FASRS, discusses ...

ENGINES revved their way down to Vautiers on Saturday, as this year’s thrilling Summer Trials Series came to a decisive conclusion. As this was the final round of the series, the stage at Vautiers was ...

Synthetic generation replicates key clinical patterns from real-world data, enabling valid analyses with fewer patients.

Several oncology companies announced key trial milestones this week across the landscape of both blood cancers and solid ...

Amgen Inc (($AMGN)) announced an update on their ongoing clinical study. Amgen Inc., in collaboration with Asher ...

Study Design: ARISE is an observational, multicenter, longitudinal study using a retrospective cohort of CLL patients who began acalabrutinib treatment between May 2021 and April 2022. The study will ...

NEW YORK – Krystal Biotech has discontinued a Phase I/II clinical trial evaluating an injected version of its gene therapy KB707 in locally advanced or metastatic solid tumors, including melanoma.

Offering a modest gift card significantly increased enrollment of low-income individuals in a patient registry designed to ...

ALEX TORDOFF is relishing the prospect of fulfilling a lifelong dream as he saddles up for his Defender Burghley Horse Trials debut.

NCX 470 0.1%, a novel nitric oxide-donating bimatoprost eye drop, achieved its primary endpoint in the phase 3 Denali ...